Contact
searchSearch
HMP Global

Aortic Interventions

Features

Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Interview
Confronting the Gender Gap in AAA Care: Women Face Worse Outcomes and What Needs to Change
02/18/2026
Jon Matsumura, MD
Despite advances, women with AAA continue to experience disproportionately higher mortality rates and remain significantly underrepresented in clinical trials.
Despite advances, women with AAA continue to experience disproportionately higher mortality rates and remain significantly underrepresented in clinical trials.
Despite advances, women with AAA...
02/18/2026
Vascular Disease Management
John S. Pellerito, MD
ISET 2026
CEUS in Vascular Imaging—EVAR Follow-Up and Beyond
02/09/2026
John S. Pellerito, MD
John S. Pellerito, MD, began his Monday morning session at ISET 2026 with a pragmatic message for vascular specialists: contrast-enhanced ultrasound (CEUS) is no longer a niche add-on in the vascular lab.
John S. Pellerito, MD, began his Monday morning session at ISET 2026 with a pragmatic message for vascular specialists: contrast-enhanced ultrasound (CEUS) is no longer a niche add-on in the vascular lab.
John S. Pellerito, MD, began his...
02/09/2026
Vascular Disease Management
Dr Tara Mastracci
LINC 2026
How to Start an Endoarch Program in a Cardiothoracic Department
01/29/2026
Tara M. Mastracci, MD
Dr Tara Mastracci shares a glimpse of her extensive experience shaping a multidisciplinary endoarch service within a cardiothoracic setting.
Dr Tara Mastracci shares a glimpse of her extensive experience shaping a multidisciplinary endoarch service within a cardiothoracic setting.
Dr Tara Mastracci shares a...
01/29/2026
Vascular Disease Management
Maria Antonello Ruffino, MD
LINC 2026
Indications, Planning, and Technical Aspects of PMEGs Based on a Cross-Sectional Global Survey
01/29/2026
Maria Antonello Ruffino, MD
Maria Antonello Ruffino shares insights from a cross-sectional survey that maps where consensus exists, where indications and planning thresholds diverge, and how geography and operator volume shape decision-making.
Maria Antonello Ruffino shares insights from a cross-sectional survey that maps where consensus exists, where indications and planning thresholds diverge, and how geography and operator volume shape decision-making.
Maria Antonello Ruffino shares...
01/29/2026
Vascular Disease Management
Dr Groenenberg
LINC 2026
Augmented Reality for Live Tracking of 3D Stent-Graft Positions During EVAR Surgery
01/28/2026
Annabel Groenenberg, MD
LINC Today spoke with Dr Annabel Groenenberg about her team’s LAMARR concept, which aims to provide live intraoperative 3D tracking of stent-graft position from a single fluoroscopy image.
LINC Today spoke with Dr Annabel Groenenberg about her team’s LAMARR concept, which aims to provide live intraoperative 3D tracking of stent-graft position from a single fluoroscopy image.
LINC Today spoke with Dr Annabel...
01/28/2026
Vascular Disease Management
Dr Armando Lobato
LINC 2026
Complex Aortic Dissection: You Either Master It—or It Takes You Down
01/28/2026
Armando Lobato, MD
In an interview with LINC Today regarding his presentation, Dr Armando Lobato set out a practical framework for decision-making in complicated acute type B and hybrid post-arch scenarios.
In an interview with LINC Today regarding his presentation, Dr Armando Lobato set out a practical framework for decision-making in complicated acute type B and hybrid post-arch scenarios.
In an interview with LINC Today...
01/28/2026
Vascular Disease Management
Moritz Bischoff, MD
LINC 2026
Is 10-Year Follow-Up Really Enough After EVAR?
01/26/2026
Moritz Bischoff, MD
Moritz Bischoff discusses how late failure modes and sac dynamics should shape risk-adapted surveillance, why patient engagement may be the decisive determinant of long-term safety, and how imaging strategies can be tailored.
Moritz Bischoff discusses how late failure modes and sac dynamics should shape risk-adapted surveillance, why patient engagement may be the decisive determinant of long-term safety, and how imaging strategies can be tailored.
Moritz Bischoff discusses how...
01/26/2026
Vascular Disease Management
Acute Type A Dissection
Gore Announces First Patient Implant of the GORE® Ascending Stent Graft for Treatment of Acute Type A Dissection in ARISE III Pivotal Study
12/15/2025
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant...
12/15/2025
Vascular Disease Management

Videos

Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Dr Joseph Lombardi
ISET 2024
Type B Aortic Dissections: An Update on When and How to Treat
02/29/2024

Joseph Lombardi, MD, FACS
Cooper Medical School of Rowan University, Camden, New Jersey

Joseph Lombardi, MD, FACS Cooper Medi...
In this video, vascular surgeon Dr. Joseph Lombardi discusses his presentation on type B aortic dissections at ISET 2024.
In this video, vascular surgeon Dr. Joseph Lombardi discusses his presentation on type B aortic dissections at ISET 2024.
In this video, vascular surgeon...
02/29/2024
Vascular Disease Management
Video
Ross Milner, MD Discusses GREAT: The Value of the Registry Based on Real-World Data
12/01/2023
Ross Milner, MD
In this video, vascular surgeon Dr. Ross Milner discusses the GREAT Registry.
In this video, vascular surgeon Dr. Ross Milner discusses the GREAT Registry.
In this video, vascular surgeon...
12/01/2023
Vascular Disease Management
Video
How Materials Science and Unique Design Features Address the Demands of TEVAR
11/01/2023

Gore Medical 

Gore Medical 
In this video, learn how the Gore TAG conformable stent graft is designed to address the demands of TEVAR.
In this video, learn how the Gore TAG conformable stent graft is designed to address the demands of TEVAR.
In this video, learn how the...
11/01/2023
Vascular Disease Management
Video
Darren Schneider, MD, Reviews Key Outcomes and Implications of 5-Year IDE Data for Iliac Branch Device
10/01/2023
Darren Schneider, MD
Watch as Dr. Darren Schneider discusses impact to perceptions on whether to sacrifice or preserve the hypogastric artery based on key outcomes from 5-year IDE data.
Watch as Dr. Darren Schneider discusses impact to perceptions on whether to sacrifice or preserve the hypogastric artery based on key outcomes from 5-year IDE data.
Watch as Dr. Darren Schneider...
10/01/2023
Vascular Disease Management
Video
Mark Farber, MD, National Principal Investigator, Comments on Blunt Thoracic Artery Injury 5-Year Results, Including the Number of Reinterventions Relative to Device Performance
09/01/2023
Mark Farber, MD
Dr. Farber comments on the U.S. IDE clinical trial.
Dr. Farber comments on the U.S. IDE clinical trial.
Dr. Farber comments on the U.S....
09/01/2023
Vascular Disease Management
Video
National Principal Investigators Share Their Perspectives on First-of-Its-Kind Zone 2 TEVAR Device
08/01/2023
Himanshu J. Patel, MD; Michael D. Dake, MD
See what Drs Himanshu J. Patel and Michael D. Dake have to say about this first-of-its kind zone 2 TEVAR device from Gore.
See what Drs Himanshu J. Patel and Michael D. Dake have to say about this first-of-its kind zone 2 TEVAR device from Gore.
See what Drs Himanshu J. Patel...
08/01/2023
Vascular Disease Management
Video
Treatment Innovation: Robert Rhee, MD, Recalls the Unmet Needs and Collaborative Efforts that Led to the Newest Gore AAA Device and Delivery System
08/01/2023
Robert Rhee, MD
Watch as Dr Robert Rhee discusses what led to the newest Gore AAA device and delivery system.
Watch as Dr Robert Rhee discusses what led to the newest Gore AAA device and delivery system.
Watch as Dr Robert Rhee...
08/01/2023
Vascular Disease Management
Video
Darren Schneider, MD, Discusses the Patient Need That Led to the Development of an Iliac Branch Solution
06/01/2023
Watch as Dr. Darren Schneider discusses how an iliac branch solution was developed based on patient needs.
Watch as Dr. Darren Schneider discusses how an iliac branch solution was developed based on patient needs.
Watch as Dr. Darren Schneider...
06/01/2023
Vascular Disease Management
Michael Pishvaian headshot
Interview
Intra-Arterial Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
06/15/2026
Michael Pishvaian, MD, PhD
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD,...
06/15/2026
Vascular Disease Management
Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
Retrievable Scaffold Therapy: Results From Trials
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
The State of DCB Technology in 2026: Where Are We Going?
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Dr Sanjay Misra speaks at ISET 2026
ISET 2026
Renal Denervation for Refractory Hypertension: Indications, Data, and Outcomes
03/25/2026
Sanjay Misra, MD, FSIR, FAHA, FACR
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist...
03/25/2026
Vascular Disease Management
Dr William Gray speaking at ISET
ISET 2026
Three-Year Outcomes from the PERFORMANCE II Trial: A Prospective Multicenter Study of the Neuroguard IEP® 3-in-1 Carotid Stent System
03/24/2026
William A. Gray, MD, FACC, FSCAI
Dr. Gray reviews the study’s design, clinical endpoints, and 3-year results, offering insight into safety, efficacy, and sustained performance.
Dr. Gray reviews the study’s design, clinical endpoints, and 3-year results, offering insight into safety, efficacy, and sustained performance.
Dr. Gray reviews the study’s...
03/24/2026
Vascular Disease Management

Presentations

John S. Pellerito, MD
ISET 2026
CEUS in Vascular Imaging—EVAR Follow-Up and Beyond
02/09/2026
John S. Pellerito, MD
John S. Pellerito, MD, began his Monday morning session at ISET 2026 with a pragmatic message for vascular specialists: contrast-enhanced ultrasound (CEUS) is no longer a niche add-on in the vascular lab.
John S. Pellerito, MD, began his Monday morning session at ISET 2026 with a pragmatic message for vascular specialists: contrast-enhanced ultrasound (CEUS) is no longer a niche add-on in the vascular lab.
John S. Pellerito, MD, began his...
02/09/2026
Vascular Disease Management
Dr Tara Mastracci
LINC 2026
How to Start an Endoarch Program in a Cardiothoracic Department
01/29/2026
Tara M. Mastracci, MD
Dr Tara Mastracci shares a glimpse of her extensive experience shaping a multidisciplinary endoarch service within a cardiothoracic setting.
Dr Tara Mastracci shares a glimpse of her extensive experience shaping a multidisciplinary endoarch service within a cardiothoracic setting.
Dr Tara Mastracci shares a...
01/29/2026
Vascular Disease Management
Maria Antonello Ruffino, MD
LINC 2026
Indications, Planning, and Technical Aspects of PMEGs Based on a Cross-Sectional Global Survey
01/29/2026
Maria Antonello Ruffino, MD
Maria Antonello Ruffino shares insights from a cross-sectional survey that maps where consensus exists, where indications and planning thresholds diverge, and how geography and operator volume shape decision-making.
Maria Antonello Ruffino shares insights from a cross-sectional survey that maps where consensus exists, where indications and planning thresholds diverge, and how geography and operator volume shape decision-making.
Maria Antonello Ruffino shares...
01/29/2026
Vascular Disease Management
Dr Groenenberg
LINC 2026
Augmented Reality for Live Tracking of 3D Stent-Graft Positions During EVAR Surgery
01/28/2026
Annabel Groenenberg, MD
LINC Today spoke with Dr Annabel Groenenberg about her team’s LAMARR concept, which aims to provide live intraoperative 3D tracking of stent-graft position from a single fluoroscopy image.
LINC Today spoke with Dr Annabel Groenenberg about her team’s LAMARR concept, which aims to provide live intraoperative 3D tracking of stent-graft position from a single fluoroscopy image.
LINC Today spoke with Dr Annabel...
01/28/2026
Vascular Disease Management
Dr Armando Lobato
LINC 2026
Complex Aortic Dissection: You Either Master It—or It Takes You Down
01/28/2026
Armando Lobato, MD
In an interview with LINC Today regarding his presentation, Dr Armando Lobato set out a practical framework for decision-making in complicated acute type B and hybrid post-arch scenarios.
In an interview with LINC Today regarding his presentation, Dr Armando Lobato set out a practical framework for decision-making in complicated acute type B and hybrid post-arch scenarios.
In an interview with LINC Today...
01/28/2026
Vascular Disease Management
Moritz Bischoff, MD
LINC 2026
Is 10-Year Follow-Up Really Enough After EVAR?
01/26/2026
Moritz Bischoff, MD
Moritz Bischoff discusses how late failure modes and sac dynamics should shape risk-adapted surveillance, why patient engagement may be the decisive determinant of long-term safety, and how imaging strategies can be tailored.
Moritz Bischoff discusses how late failure modes and sac dynamics should shape risk-adapted surveillance, why patient engagement may be the decisive determinant of long-term safety, and how imaging strategies can be tailored.
Moritz Bischoff discusses how...
01/26/2026
Vascular Disease Management
Chiara Lomazzi and Santi Trimarchi
LINC 2025
10-Year Results of the GREAT Registry: Lessons Learned From More Than 30 Publications
01/29/2025
Santi Trimarchi, MD,and Chiara Lomazzi, MD, presented the aims of the GREAT Registry, relaying its contemporary real-world data on aortic endografts in the treatment of multiple aortic pathologies.
Santi Trimarchi, MD,and Chiara Lomazzi, MD, presented the aims of the GREAT Registry, relaying its contemporary real-world data on aortic endografts in the treatment of multiple aortic pathologies.
Santi Trimarchi, MD,and Chiara...
01/29/2025
Vascular Disease Management
Dr Tsilimparis
LINC 2024
Physician-modified Endografts on Trial
05/30/2024

Nikolaos Tsilimparis, MD
University Hospital of Munich, Germany

Nikolaos Tsilimparis, MD University H...
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified...
05/30/2024
Vascular Disease Management
Dr Donas
LINC 2023
EnChEVAR: A Force for Standardization
06/08/2023
Konstantinos Donas, MD
Rather than a ‘bailout’ procedure for the chimney technique, EnChEVAR could become a standardized, therapeutic, complementary option.
Rather than a ‘bailout’ procedure for the chimney technique, EnChEVAR could become a standardized, therapeutic, complementary option.
Rather than a ‘bailout’...
06/08/2023
Vascular Disease Management
Dr Verhagen
LINC 2023
Trial Set to ADVANCE Knowledge in Sac Regression
06/07/2023
Hence Verhagen, MD
An important head-to-head RCT of 2 leading aortic stent-graft systems were discussed on Wednesday by Hence Verhagen, Chief of Vascular Surgery at Erasmus University Medical Center in Rotterdam, the Netherlands.
An important head-to-head RCT of 2 leading aortic stent-graft systems were discussed on Wednesday by Hence Verhagen, Chief of Vascular Surgery at Erasmus University Medical Center in Rotterdam, the Netherlands.
An important head-to-head RCT of...
06/07/2023
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Dr Elizabeth Genovese
ISET 2026
When Do I Think of a Bypass? Reframing Revascularization Decisions in CLTI
02/11/2026
Elizabeth Genovese, MD, MS, FACS, RPVI
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a...
02/11/2026
Vascular Disease Management
Dr William Kuo
ISET 2026
Clot Management in the IVC: Matching the Device to the Disease
02/11/2026
William T. Kuo, MD
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon...
02/11/2026
Vascular Disease Management
John Rundback MD
ISET 2026
Vessel Preparation for Tibial Interventions: Why “Just PTA” Is Rarely Enough
02/11/2026
John H. Rundback, MD, FAHA, FSIR
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges...
02/11/2026
Vascular Disease Management
John Fritz Angle, MD
ISET 2026
AVM Embolization Strategies: Tools and Tactics That Work
02/10/2026
John Fritz Angle, MD
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John...
02/10/2026
Vascular Disease Management
Sean P. Lyden, MD
ISET 2026
Real-World Acute Limb Ischemia: What the PROWL Registry Is Teaching Us
02/10/2026
Sean P. Lyden, MD
Sean P. Lyden, MD, discussed new real-world data from the PROWL Registry, offering a look at how acute, subacute, and CLTI are being treated outside the confines of traditional clinical trial exclusions.
Sean P. Lyden, MD, discussed new real-world data from the PROWL Registry, offering a look at how acute, subacute, and CLTI are being treated outside the confines of traditional clinical trial exclusions.
Sean P. Lyden, MD, discussed new...
02/10/2026
Vascular Disease Management
Dr Andrew Holden
ISET 2026
Bioresorbable Scaffolds in BTK Disease: Where We Are and Where We’re Headed
02/10/2026
Andrew Holden, MBChB
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a...
02/10/2026
Vascular Disease Management
Ripal T. Gandhi, MD
ISET 2026
Single-Use Handheld Vascular Robotics: What Is the Future?
02/10/2026
Ripal T. Gandhi, MD, FSIR, FSVM
Ripal T. Gandhi, MD, FSIR, FSVM, explored how single-use, handheld robotic systems could shape the next phase of peripheral endovascular intervention.
Ripal T. Gandhi, MD, FSIR, FSVM, explored how single-use, handheld robotic systems could shape the next phase of peripheral endovascular intervention.
Ripal T. Gandhi, MD, FSIR, FSVM,...
02/10/2026
Vascular Disease Management
James F. Meschia, MD
ISET 2026
Redefining Optimal Medical Therapy in Carotid Disease: Key Lessons from CREST-2
02/09/2026
James F. Meschia, MD
James F. Meschia, MD, provides an overview of what “optimal medical therapy” means in contemporary carotid disease management.
James F. Meschia, MD, provides an overview of what “optimal medical therapy” means in contemporary carotid disease management.
James F. Meschia, MD, provides...
02/09/2026
Vascular Disease Management
Nicos Labropoulos, MD
ISET 2026
Beyond Stenosis: Identifying the Truly High-Risk Carotid Plaque
02/09/2026
Nicos Labropoulos, MD
Nicos Labropoulos, MD, presented an overview of what defines a “high-risk” carotid plaque and why relying on luminal stenosis alone is no longer enough.
Nicos Labropoulos, MD, presented an overview of what defines a “high-risk” carotid plaque and why relying on luminal stenosis alone is no longer enough.
Nicos Labropoulos, MD, presented...
02/09/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Acute Type A Dissection
Gore Announces First Patient Implant of the GORE® Ascending Stent Graft for Treatment of Acute Type A Dissection in ARISE III Pivotal Study
12/15/2025
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant...
12/15/2025
Vascular Disease Management
News
Final Patient Treated in ZENITH® FENESTRATED+ Endovascular Graft Clinical Study
08/28/2025
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL...
08/28/2025
Vascular Disease Management
Aortic Arch Repair
GORE® TAG® Thoracic Branch Endoprosthesis (TBE) Now Indicated for Zone 0 and Zone 1 Aortic Arch Repairs
06/23/2025
The first off-the-shelf, on-label branched endovascular device for Zones 0, 1 and 2 FLAGSTAFF, Ariz. (June 23, 2025) — W. L. Gore & Associates Medical Products (Gore) today announced that the GORE® TAG® Thoracic Branch Endoprosthesis...
The first off-the-shelf, on-label branched endovascular device for Zones 0, 1 and 2 FLAGSTAFF, Ariz. (June 23, 2025) — W. L. Gore & Associates Medical Products (Gore) today announced that the GORE® TAG® Thoracic Branch Endoprosthesis...
The first off-the-shelf,...
06/23/2025
Vascular Disease Management
Aortic Lesions
Gore Announces FDA Approval and First Commercial Implant of Large-Diameter Thoracic Tapers
04/03/2025
FLAGSTAFF, Ariz. (March 24, 2025) — W. L. Gore & Associates (Gore) today announced the expansion of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System product line, following FDA approval of four new large-diameter...
FLAGSTAFF, Ariz. (March 24, 2025) — W. L. Gore & Associates (Gore) today announced the expansion of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System product line, following FDA approval of four new large-diameter...
FLAGSTAFF, Ariz. (March 24,...
04/03/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management
AAA Endoprosthesis
First Commercial Implant of the Gore® Excluder® Conformable AAA Endoprosthesis With Active Control System in Canada
01/27/2025
Bringing physicians a new degree of control and conformability FLAGSTAFF, Ariz. (January 10, 2025) — W. L. Gore & Associates Medical Products (Gore) today announced the first commercial use of the GORE® EXCLUDER® Conformable AAA...
Bringing physicians a new degree of control and conformability FLAGSTAFF, Ariz. (January 10, 2025) — W. L. Gore & Associates Medical Products (Gore) today announced the first commercial use of the GORE® EXCLUDER® Conformable AAA...
Bringing physicians a new degree...
01/27/2025
Vascular Disease Management
News
Echo IQ Signs Integration Agreement With Flagship US Hospital
12/12/2024
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
The integration follows the...
12/12/2024
Vascular Disease Management
Bridging Stent for FEVAR
World premiere for Bentley’s BeFlared Bridging Stent: Successful “First in Man” Operation
12/02/2024
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024...
12/02/2024
Vascular Disease Management
News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
Abdominal Aortic Aneurysm
Data Presented on Two-Year Proximal Neck Dynamics From First-in-Human Study of Abdominal Aortic Aneurysm Treatment
06/26/2026
Tempe, AZ – June 25, 2026 – Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with pentagalloylglucose (PGG) using its investigational...
Tempe, AZ – June 25, 2026 – Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with pentagalloylglucose (PGG) using its investigational...
Tempe, AZ – June 25, 2026 –...
06/26/2026
Vascular Disease Management
New Guiding Sheath
Volante™ Steerable Guiding Sheath Now Available in US
06/23/2026
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The...
06/23/2026
Vascular Disease Management
Clinical Trials
SYMPHONY-PE Trial Post-Hoc Analysis Suggests Early Thrombectomy May Improve Key Measures of Heart Recovery in Intermediate-Risk Pulmonary Embolism
06/18/2026
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12...
06/18/2026
Cath Lab Digest
Team Communication
IB Nimble 2 Adds In-App DICOM Viewing for Real-Time Multidisciplinary Collaboration
06/17/2026
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is...
06/17/2026
Cath Lab Digest
CE Mark
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
06/16/2026
The THUNDERBOLT™ Computer Assisted Vacuum Thrombectomy (CAVT™) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal.
The THUNDERBOLT™ Computer Assisted Vacuum Thrombectomy (CAVT™) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal.
The THUNDERBOLT™ Computer...
06/16/2026
Cath Lab Digest
FDA Clearance
Penumbra’s THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
06/15/2026
Powered by the Penumbra ENGINE™, THUNDERBOLT introduces modulated aspiration to Penumbra’s neuro thrombectomy portfolio, offering advanced CAVT technology designed to detect, fatigue, and completely ingest clot at the site of the occlusion. 
Powered by the Penumbra ENGINE™, THUNDERBOLT introduces modulated aspiration to Penumbra’s neuro thrombectomy portfolio, offering advanced CAVT technology designed to detect, fatigue, and completely ingest clot at the site of the occlusion. 
Powered by the Penumbra ENGINE™,...
06/15/2026
Cath Lab Digest
Veterans With PAD
Department of Veteran Affairs Referrals for Peripheral Artery Disease Nearly Triples Over the Past Five Years
06/15/2026
More than 180,000 veterans receive care for PAD in Department of Veterans Affairs hospitals.
More than 180,000 veterans receive care for PAD in Department of Veterans Affairs hospitals.
More than 180,000 veterans...
06/15/2026
Cath Lab Digest
Thrombolex, Inc.
Thrombolex, Inc. Names Michael Tutera Chief Executive Officer
06/12/2026
New Britain, PA, June 15, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, June 15, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, June 15, 2026 –...
06/12/2026
Vascular Disease Management
PAD Guidelines
VAM26: Complete Adherence to Guideline-Directed Care Associated with Decreased Serious Limb Complications at Two Years
06/10/2026
“Our study was designed to establish the evidence of a comprehensive multidisciplinary approach before considering surgical intervention,” said Dr. Richard Shi, vascular surgery resident at the Medical University of South Carolina. “Too...
“Our study was designed to establish the evidence of a comprehensive multidisciplinary approach before considering surgical intervention,” said Dr. Richard Shi, vascular surgery resident at the Medical University of South Carolina. “Too...
“Our study was designed to...
06/10/2026
Cath Lab Digest
Thrombectomy
First-in-Human Clinical Success with Novel Mechanical Thrombectomy System
06/09/2026
"The V-PULSE system removed significant clot burden and provided immediate visual confirmation of thrombus capture through its integrated filtration technology," said Makmood Razavi, MD.
"The V-PULSE system removed significant clot burden and provided immediate visual confirmation of thrombus capture through its integrated filtration technology," said Makmood Razavi, MD.
"The V-PULSE system removed...
06/09/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use